Hepion Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Hepion Pharmaceuticals has a total shareholder equity of $7.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $16.0M and $8.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$13.11m |
Equity | US$7.52m |
Total liabilities | US$8.47m |
Total assets | US$15.99m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 336's short term assets ($15.4M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: 336's short term assets ($15.4M) exceed its long term liabilities ($5.9M).
Debt to Equity History and Analysis
Debt Level: 336 is debt free.
Reducing Debt: 336 has no debt compared to 5 years ago when its debt to equity ratio was 294.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 336 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 336 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.2% each year